In many of these patients a clinical suspicion of PCa persists, however, based on sustained elevated serum prostate-specific antigen (PSA), abnormal digital rectal examination (DRE) findings and/or suspicious lesions on magnetic resonance imaging (MRI). The gene discussed is KLK3; the disease is posterior cortical atrophy.